Menu
1-702-720-6310 info@microcapspecualtors.com

Why This Biotech Could Be Poised For A Run After Toppling 52% In June – Investor’s Business Daily


Investor’s Business Daily

Why This Biotech Could Be Poised For A Run After Toppling 52% In June
Investor’s Business Daily
Cara Therapeutics (CARA) stock popped Wednesday after the biotech unveiled strong data from a Phase 1 drug trial for chronic kidney disease patients — giving its shares a leg up for the second day running. XAutoplay: On | OffCara shares have been …

and more »

Search